Oslo Pharma Invest AS is a Norwegian AS based in Oslo, operating in the Rental and operating of own or leased real estate sector. Incorporated in 2008, the company has 0 employees and reported revenue of 5,9 mill. kr in its latest annual filing.
In its most recent annual report (2024), Oslo Pharma Invest AS reported revenue of 5,9 mill. kr, an increase of 7% on the year before. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net profit of 6,9 mill. kr, and the EBITDA margin stood at 82%.
At the end of 2024, equity financed 36.8% of the balance sheet, and current assets covered short-term debt 3.5 times.
Frequently asked questions
What is the Org number of Oslo Pharma Invest AS?
Oslo Pharma Invest AS is registered with Brønnøysundsregistrene under Org 992915927.
What is the revenue of Oslo Pharma Invest AS?
Oslo Pharma Invest AS reported revenue of 5,9 mill. kr in 2024.
Who is the CEO of Oslo Pharma Invest AS?
Johnny Ng is the CEO of Oslo Pharma Invest AS.
Who is the chairman of Oslo Pharma Invest AS?
Johnny Ng chairs the board of Oslo Pharma Invest AS.
Where is Oslo Pharma Invest AS headquartered?
Oslo Pharma Invest AS's registered address is Steinliveien 1A, 1185 Oslo.
